- Surgical Considerations for Tumor Tissue Procurement to Obtain Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy
John E. Mullinax et al, 2022, The Cancer Journal CrossRef - The impact of inflammatory cells in malignant ascites on small intestinal ICCs' morphology and function
Jing Li et al, 2015, Journal of Cellular and Molecular Medicine CrossRef - Recent development in biodegradable nanovehicle delivery system-assisted immunotherapy
Zhenfu Wen et al, 2019, Biomaterials Science CrossRef - Generating CAR T cells from tumor-infiltrating lymphocytes
Jane K. Mills et al, 2021, Therapeutic Advances in Vaccines and Immunotherapy CrossRef - Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy
Allison Betof Warner et al, 2024, Journal for ImmunoTherapy of Cancer CrossRef - Local antitumor effects of intratumoral delivery of rlL-2 loaded sustained-release dextran/PLGA–PLA core/shell microspheres
Haiping Zhao et al, 2013, International Journal of Pharmaceutics CrossRef - Cancer Immunotherapies: What the Perioperative Physician Needs to Know
Robert S. Ackerman et al, 2022, Current Oncology Reports CrossRef - Potent Activation of Human T Cells by mRNA Encoding Constitutively Active CD40
Noam Levin et al, 2018, The Journal of Immunology CrossRef - Are BiTEs the “missing link” in cancer therapy?
Carter M Suryadevara et al, 2015, OncoImmunology CrossRef